Lucira Health to Announce First Quarter 2021 Financial Results
April 29 2021 - 4:00PM
Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a
medical technology company focused on the development and
commercialization of transformative and innovative infectious
disease test kits, today announced that the company will report
first quarter ended March 31, 2021 financial results on Thursday,
May 13, 2021. Lucira’s management will host a conference call and
webcast at 1:30 p.m. PT / 4:30 p.m. ET that day to discuss the
financial results and provide a corporate update.
Conference Call and Webcast DetailsThe
conference call can be accessed by dialing (833) 562-0151 for
participants in the U.S. or Canada and (661) 567-1232 for
international callers, using conference ID 3562914. A live and
archived webcast of the event can be accessed via the Investors
page of the investor section of Lucira's website.
About Lucira HealthLucira Health is a medical
technology company focused on the development and commercialization
of transformative and innovative infectious disease test kits.
Lucira’s testing platform produces lab quality molecular testing in
a single-use, consumer-friendly, palm size test kit powered by two
AA batteries. Lucira designed its test kits to provide accurate,
reliable and on-the-spot molecular tests results anywhere and
anytime. The LUCIRA CHECK IT (OTC) and LUCIRA COVID-19 All-In-One
Test Kits (RX) are designed to provide a clinically relevant
COVID-19 result within 30 minutes from sample collection. For more
information, visit www.lucirahealth.com.
Investor Contact Greg Chodaczek
Investorrelations@lucirahealth.com347-620-7010
Media Contact Kevin Knight
media@lucirahealth.com 206-451-4823
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Apr 2023 to Apr 2024